Aura Biosciences

Aura Biosciences is a biotechnology company dedicated to developing drugs through the use of targeted pseudoviral particles, creating an entirely new class of precision-targeted therapies—nanovirus conjugates. These nanovirus particles act as "precision-guided" carriers for anti-cancer drug molecules, enabling them to bind specifically to cancer cells. This approach selectively destroys cancer cells without harming normal cells. The company's mission is to develop a series of highly selective, precision-targeted cancer therapies aimed at improving the quality of life for patients with various tumors that are currently underserved by existing treatments. It also seeks to address the lack of effective therapies for rare cancers, creating new treatment opportunities for these conditions.